Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion

Background. Ranibizumab is approved for treatment of macular edema in eyes with retinal vein occlusion (RVO). Some eyes show low-response to treatment with regard to visual acuity gain (VA) and OCT central retinal thickness (CRT) reduction. The goal of this study was to quantify the percentage of lo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Ophthalmol
Main Authors: Menke, Marcel N., Ebneter, Andreas, Zinkernagel, Martin S., Wolf, Sebastian
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156818/
https://ncbi.nlm.nih.gov/pubmed/28044102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9875741
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados